Post-Transplant Hypertension in Kidney Recipients: Current Knowledge, Gaps and Future Directions
Alicja Danieluk, Tomasz Pilecki, Bartosz Rutka, Krzysztof Mucha · 2026
Read Post-Transplant Hypertension in Kidney Recipients: Current Knowledge, Gaps and Future Directions by Alicja Danieluk, Tomasz Pilecki, Bartosz Rutka, Krzysztof Mucha (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13301542.txt.
Description
High blood pressure follows most kidney transplant patients home, and Alicja Danieluk with colleagues review what is known, and what is missing, in a 2026 survey of post-transplant hypertension. Between seventy and ninety-five percent of recipients live with it, and heart disease remains their leading killer. The authors scan guidelines, drug evidence, and the transplant-specific drivers of pressure.
Calcium channel blockers and angiotensin receptor blockers still lead treatment, though the trials behind them are old. The 2024 KDIGO guidance skips transplant blood pressure entirely, leaving targets borrowed from other populations. Trimming calcineurin inhibitors or steroids, or switching agents, can help some patients. Fresh randomized trials in recipients top the authors' wish list.
Catalog record
| CREATOR | Alicja Danieluk, Tomasz Pilecki, Bartosz Rutka, Krzysztof Mucha |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33282 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |